Cargando…
Modelling of longitudinal outcomes with highly skewed distributions: applications in the IVAN trial
Autores principales: | Nash, R, Scott, L, Chakravarthy, U, Harding, SP, Reeves, BC, Rogers, CA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981619/ http://dx.doi.org/10.1186/1745-6215-14-S1-O39 |
Ejemplares similares
-
Changes in intraocular pressure in study and fellow eyes in the IVAN trial
por: Foss, Alexander J E, et al.
Publicado: (2016) -
Designing, implementing and analysing a virtual trial
por: Scott, Lauren J, et al.
Publicado: (2015) -
Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial
por: Evans, Rebecca N., et al.
Publicado: (2020) -
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial
por: Dakin, Helen A, et al.
Publicado: (2014) -
Serum Vascular Endothelial Growth Factor Levels in the IVAN Trial; Relationships with Drug, Dosing, and Systemic Serious Adverse Events
por: Rogers, Chris A., et al.
Publicado: (2018)